Source: Eur Respir Rev, 28 (154) 190031; 10.1183/16000617.0031-2019
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
Nejat Altintas, Renata L. Riha. Non-sleepy obstructive sleep apnoea: to treat or not to treat?. Eur Respir Rev, 28 (154) 190031; 10.1183/16000617.0031-2019

Member's Comments

No comment yet.

Related content which might interest you: Minimally symptomatic obstructive sleep apnoea: to treat or not to treat? Source: 5th Sleep and Breathing Conference Year: 2019 Can leptin be used to treat obstructive sleep apnoea? Source: International Congress 2019 – New horizons for pharmacotherapy of sleep-disordered breathing: from bench to bedside Year: 2019 Obese children with obstructive sleep apnoea syndrom: how to treat? Source: International Congress 2019 – Phenotypes and personalised treatment of obstructive sleep apnoea in children Year: 2019 Treating obstructive sleep apnoea to improve control of hypertension Source: International Congress 2014 – ERS/JAMA lunchtime session: 2014 highlights Year: 2014 Should caffeine be avoided in obstructive sleep apnea? Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea Year: 2009 Positional therapy for obstructive sleep apnea: do your patients use it at home? Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea Year: 2009 Ato-oxy as the first successful pharmacotherapy for obstructive sleep apnoea Source: International Congress 2019 – New horizons for pharmacotherapy of sleep-disordered breathing: from bench to bedside Year: 2019 Tailoring surgical interventions to treat obstructive sleep apnoea: one size does not fit all Source: Breathe, 14 (3) e84; 10.1183/20734735.020118 Year: 2018 Should mixed apnea be classified with obstructive sleep apnea? Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea Year: 2009 Treatment of obstructive and central sleep apnoea in heart failure: practical options Source: Eur Respir Rev 2007; 16: 183-188 Year: 2007 Personalised approach to treatment of children with obstructive sleep apnoea: what is the evidence? Source: Sleep and Breathing Conference 2021 Year: 2021 Metabolic disturbances in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) patients Source: Annual Congress 2010 - Clinical aspects of sleep apnoea Year: 2010 Surgical approaches to the treatment of obstructive sleep apnea Source: Virtual Congress 2020 – New technologies for the management of COPD and obstructive sleep apnea and the diagnosis of lung cancer Year: 2020 Does auto-CPAP improve the quality of sleep in obstructive sleep apnoea (OSA)? Source: Eur Respir J 2001; 18: Suppl. 33, 418s Year: 2001 Metabolic syndrome in moderate to severe obstructive sleep apnea? Source: Virtual Congress 2020 – Consequences for obstructive sleep apnoea and potential modalities for early identification Year: 2020 Treatment of obstructive sleep apnoea: differential surgical approach Source: Eur Respir J 2003; 22: Suppl. 45, 96s Year: 2003 AutoCPAP devices accurately identify obstructive sleep apnea patients with residual apnea during treatment Source: Annual Congress 2011 - Obstructive sleep apnoea : physiology, diagnostic tools and technology Year: 2011 Incidence of cardiovascular complications in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders Year: 2007